# Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

> **NCT01702337** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **OTHER:** Prevalence-based model

## Key facts

- **NCT ID:** NCT01702337
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2012-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702337, "Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01702337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*